Becton, Dickinson and Company
https://www.bd.com/en-us
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Becton, Dickinson and Company
News We’re Watching: $1B Judgement Against J&J; Recalls For Abbott, Baxter, More; Karl Storz Announces Fujifilm Partnership
This week, a Delaware court awarded Auris Health shareholders $1bn in a lawsuit against Johnson & Johnson; Abbott recalled some FreeStyle Libre 3 sensors; and McKesson purchased a controlling interest in a Florida cancer care chain.
J&J Interested In ‘Differentiated’ Obesity Assets
“It would be an area of interest to us,” Johnson & Johnson CEO Joaquin Duato said of the obesity space during the Morgan Stanley Healthcare Conference.
Multiple Chinese Firms Expand Global Phase III Trials To Japan
The efforts add up to a new trend after Chinese pharma firms embarked on a quest to launch pivotal Phase II or III trials worldwide, especially in the US and Europe, over the past decade. Meanwhile, BeiGene, Hengrui and others are advancing late-stage programs in the US.
Mecobalamin For ALS Among New Japan Recommendations
Japan has issued positive approval recommendations for 10 new drugs, including Catalyst’s Firdapse and Idorsia/Nxera’s Quviviq, as well as a global-first nod for mecobalamin in ALS.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
- Diagnostic Equipment & Supplies
- Implantable Devices
-
Biotechnology
- Drug Discovery Tools
- Other Names / Subsidiaries
-
- BD
- BD Medical
- Bridger Biomed, Inc.
- Caesarea Medical Electronics
- CareFusion
- Carmel Pharma, Inc.
- Carmel Pharma, AB
- Cellular Research, Inc.
- C.R. Bard, Inc.
- CRISI Medical Systems
- Davol, Inc.
- Embo Medical Limited
- FlowCardia, Inc.
- GenCell Biosystems, Ltd.
- GeneOhm Sciences
- Liberator Medical, Inc.
- Lutonix, Inc.
- Medafor, Inc.
- Medicon, Inc.
- Neomend, Inc.
- Sirigen Group Limited
- TriPath Imaging
- TVA Medical, Inc.
- Rochester Medical, Inc.
- Safety Syringes Inc.
- Vascular Pathways, Inc.
- Venclose, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice